Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04341623 · ClinicalTrials.gov registry record · NA
Xerosis and Use of Topical Moisturizer
A NA study of Xerosis Due to Atopic Dermatitis, sponsored by Wake Forest University Health Sciences.
- Active
- Registry status
- NA
- Development phase
- 35
- Enrollment target
- 1
- Study location
NCT04341623 is a NA study of Xerosis Due to Atopic Dermatitis that is active but no longer recruiting, run by Wake Forest University Health Sciences. The registered enrollment target is 35 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04341623, a NA study of Xerosis Due to Atopic Dermatitis, is active but no longer recruiting, sponsored by Wake Forest University Health Sciences.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary hypothesis is that routine measurement of trans epidermal water loss (TEWL) rates and stratum corneum (SC) hydration levels will promote patient adherence to maintenance moisturizer therapy and prevent disease relapse. The project will consist of a trial in which thirty subjects with xerosis receive moisturizer therapy and are randomized to receive either no intervention, a weekly electronic survey to assess patient's response to daily moisturizer, or daily monitoring of the effectiveness of a moisturizer with a portable hydration measurement device. The study team will measure adherence to daily moisturizer use objectively in all three groups with electronic monitors attached to the containers of the moisturizer. The adherence measure will allow the study determine how well moisturizers work for xerosis when that are well used. The study team anticipate that in the no intervention group, adherence will be abysmal and that in the group reporting their response to treatment weekly, adherence will be much better. This will give the study team negative and positive controls for assessing the effect of home barrier monitoring on treatment adherence.
Conditions Studied
Interventions
- OTHER Cetaphil Pro Eczema moisturizer
- BEHAVIORAL Electronic interaction
- BEHAVIORAL GPSkin
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences Department of Dermatology - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2021-01-21 |
| Est. Completion | 2026-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04341623
The ClinicalTrials.gov registry entry for NCT04341623 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Xerosis Due to Atopic Dermatitis appearing as the primary indexed condition, and to 3 interventions - of which Cetaphil Pro Eczema moisturizer is the first listed.
NCT04341623 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT04341623 about?
NCT04341623 is a clinical study titled "Xerosis and Use of Topical Moisturizer". The primary hypothesis is that routine measurement of trans epidermal water loss (TEWL) rates and stratum corneum (SC) hydration levels will promote patient adherence to maintenance moisturizer therapy and prevent disease relapse. The project will consist of a trial in which thirty subjects with xer...
What is the current status of trial NCT04341623?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 35 participants. The study started on 2021-01-21. Estimated completion is 2026-08.
What conditions does trial NCT04341623 study?
This clinical trial studies the following conditions: Xerosis Due to Atopic Dermatitis.
What interventions are being tested in trial NCT04341623?
The interventions under investigation include: Cetaphil Pro Eczema moisturizer (OTHER), Electronic interaction (BEHAVIORAL), GPSkin (BEHAVIORAL).
Who is sponsoring clinical trial NCT04341623?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04341623 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.